Legal Action to Consolidate Ozempic/Wegovy Lawsuits in New Jersey Over Vision Loss Concerns

What is NAION and How is it Linked to Ozempic and Wegovy?

Non-arteritic anterior ischemic optic neuropathy (NAION) is a rare eye condition that causes sudden vision loss due to a lack of blood flow to the optic nerve. Several patients who used Ozempic or Wegovy, medications primarily prescribed for Type 2 diabetes and weight loss, have developed NAION. Research has indicated a disturbing connection between these drugs and the onset of permanent vision loss.

Growing Evidence of Vision Loss from Ozempic and Wegovy Use

Studies, including one published in JAMA Ophthalmology and another from Harvard’s Mass Eye and Ear Institute, have found a significant link between Ozempic and NAION. Individuals who took semaglutide-based drugs like Ozempic and Wegovy were found to have a higher risk of developing NAION, especially those using the drugs for weight loss. In fact, diabetic users of the medication were four times more likely to develop the condition, while non-diabetic users faced an even greater risk of seven times.

We Seek to Consolidate Lawsuits in New Jersey State Court

Along with four other law firms, we’ve filed a formal request to centralize all Ozempic/Wegovy NAION lawsuits in Middlesex County, New Jersey. We’re representing victims across the country who have suffered from this devastating side effect. Our recent filing highlights several cases, including one from a 60-year-old woman who developed NAION after using Ozempic.

Why Consolidating Lawsuits Matters for Victims of Ozempic and Wegovy

Consolidating these lawsuits before one judge can help streamline the legal process, making it more efficient for plaintiffs seeking justice. Centralization is crucial for managing the increasing number of cases and ensuring consistent rulings on important legal questions related to the side effects of these drugs. For more information about our efforts to consolidate these lawsuits and how victims can get involved, read the full article on PR Newswire here, where we discuss the details of the legal filing and how it impacts the ongoing litigation.

Legal Support for Victims of Ozempic and Wegovy

At Parker Waichman LLP, we’re offering free case evaluations for individuals who have suffered from vision loss or other complications due to Ozempic and Wegovy. Victims of permanent vision loss, blindness, or optic nerve damage caused by these medications may be entitled to compensation.

If you or a loved one has experienced adverse effects from Ozempic or Wegovy, contact us for a free consultation at 800-968-7529 or visit our Ozempic, Wegovy, and Mounjaro practice area page for more information on how we can help.